WalkMe Announces Launch of Initial Public Offering

SAN FRANCISCO, June 7, 2021 /PRNewswire/ — WalkMe Ltd. (“WalkMe”), a leading provider of digital adoption solutions, today announced the launch of its initial public offering of 9,250,000 of its ordinary shares. The underwriters will have a 30-day option to purchase up to an additional 1,387,500 ordinary shares at the initial public offering price, less underwriting discounts and commissions.

WalkMe Announces Launch of Initial Public Offering Read More »

Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings

SINGAPORE, May 26, 2021 – Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, a reputable, long-term institutional investor, and other sophisticated investors.

Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings Read More »

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

MAY 26, 2021 – SINGAPORE & SAN CARLOS, Calif.–Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies errors in the complex genetic codes of diseases, fixing them with precise therapeutic solutions.

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics Read More »

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery

SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has completed a $14 million fundraising round co-led by new investor EDBI together with existing investors Anzu Partners and University of Tokyo Edge Capital Partners (UTEC).

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery Read More »

EDBI Newsletter 2021 Q1

SPAC wave arrives in Southeast Asia. The ongoing surge of SPAC-related activities
in the US arrived on the shores of Southeast Asia in recent months, with Grab announcing
their record-breaking deal and planned NASDAQ listing followed by news of other SPAC
developments from the likes of Traveloka, PropertyGuru and Bukalapak as well as
regulatory consultations by regional bourses including in Singapore and
Indonesia, underscoring the region’s ability to produce successful global companies.

EDBI Newsletter 2021 Q1 Read More »